O'Day Daniel Patrick 4
Research Summary
AI-generated summary
Gilead (GILD) CEO Daniel O'Day Sells 15,000 Shares
What Happened Daniel Patrick O'Day, Chairman & CEO of Gilead Sciences (GILD), disposed of 15,000 shares on July 1, 2026 in two reported transactions. He sold 11,900 shares at $126.09 each for $1,500,467 and 3,100 shares at $127.08 each for $393,933, for total proceeds of approximately $1,894,400. These were sales (dispositions), not purchases.
Key Details
- Transaction dates: July 1, 2026; Form 4 filed July 2, 2026 (timely filing).
- Reported trades:
- 11,900 shares @ $126.09 = $1,500,467
- 3,100 shares @ $127.08 = $393,933
- Total shares sold: 15,000; total proceeds ≈ $1,894,400.
- Footnotes:
- F1: Trades were made pursuant to a Rule 10b5-1 trading plan adopted Feb 25, 2026.
- F2/F3: Reported sale-price ranges for the two blocks are $125.59–$126.55 and $126.595–$127.44; detailed per-price breakdown is available upon request.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Transaction type code: S = Sale (disposition).
Context Sales executed under a 10b5-1 plan are pre-arranged and typically indicate pre-planned dispositions rather than ad-hoc trading based on nonpublic information. For retail investors, such planned sales are common for executives to diversify or meet personal liquidity needs; they are not a direct, unambiguous signal about the company's near-term prospects.